Sign in
TerminatedNo phase

The Efficacy & Safety of rTMS for Upper-limb Motor Function Recovery in Subcortical and Brainstem Stroke

Key facts

Who runs it
Seoul National University Bundang Hospital
Where
South Korea2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
60 people enrolled
Started
2 Jan 2023
Ended
31 Dec 2025
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Low-frequency rTMS (experimental)
  • Low-frequency rTMS (sham comparator)
Record updated
12 January 2026
Why it stopped
Due to difficulty in patient recruitment

Who can take part

Age
19 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • 19-80 years old
  • Radiologically confirmed ischemic stroke with subcortical and brainstem lesions within 90 days
  • Fugl-Meyer assessment scale (upper extremity) > 15
  • Mini-mental status exam (the Korean version) > 14 with appropriate cognitive function
  • Written informed consent

Who cannot take part

  • Previous history of stroke
  • Previous history of brain surgery
  • Intracranial metal implant
  • Inability to receive regular physical or occupational therapy
  • Hemorrhagic stroke or traumatic brain injury
  • Cerebellar stroke
  • Need for intensive care due to complications associated with stroke (e.g. pneumonia, infection, hemodynamic instability)
  • History of psychological or neurological diseases
  • History of pain or muscular weakness of upper limbs which may interfere with rehabilitation
  • History of seizure or epilepsy
  • Disagreement to use contraception in women of childbearing age
  • Fugl-Meyer assessment scale (wrist) < 1 or Fugl-Meyer assessment scale (hand) < 1
  • Traumatic brain injury
  • Aphasia
  • Skin lesions in the stimulation site of scalp

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this study is to evaluate the efficacy and safety of repetitive transcranial magnetic stimulation applied with an electromagnetic therapy stimulator 'ALTMS-A' for upper-limb motor function recovery with the sham control group for those who need upper-limb rehabilitation treatment for subcortical and brainstem stroke

The 2 groups in the trial

  • real rTMSTreatment being tested

    Use the real rTMS coil

    Treatment: Low-frequency rTMS (experimental)

  • sham rTMSSham treatment, for comparison

    Use the sham rTMS coil

    Treatment: Low-frequency rTMS (sham comparator)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Multi-center, Prospective, Comparative, Randomized, Double Blind, Superior, Pivotal Study to Compare and Evaluate the Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation Applied With an Electromagnetic Therapy Stimulator 'ALTMS-A' for Upper-limb Motor Function Recovery With the Sham Control Group for Those Who Need Upper-limb Rehabilitation Treatment for Subcortical and Brainstem Stroke (Ischemic)
Publications
Record updated
12 January 2026